DCAT Value Chain Insights

Pharma Industry CEOs, Congress Address Drug Pricing

At a Congressional hearing last week, executives from AbbVie, AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., and Pfizer examined drug pricing as part of a larger policy debate on...

FDA Outlines New Pathway for Competitive Generic Therapies

As part of its Drug Competition Action Plan, the US Food and Drug Administration (FDA) has issued draft guidance to outline a new regulatory pathway for “competitive generic therapies” (CGTs) to...

A winning pediatric dosage formulation

Information
March 6, 2019
Sponsored by Cambrex

When a global pharmaceutical company’s pediatric formulation and dosage form(s) didn’t fit the plant equipment profile used to manufacture the adult dosage form at the customer’s facility, they...

Read More
Cambrex eBook - Small molecules 2.0: the bigger picture

Information
February 20, 2019
Sponsored by Cambrex

The Cambrex eBook contains 30 more thought leading articles from the world's fastest growing small molecule company. Discover the highest number of NCEs approved by the FDA.

Read More
Continuous Flow for APIs and Intermediates (Part 2)

Information
February 13, 2019
Sponsored by Cambrex

Cambrex’s Dr. Shawn Conway, Director of Engineering, R&D, outlines how continuous flow processes simplify and break through traditional method limitations to achieve efficiencies in cost, quality and...

Read More